Bellus Health
BELLUS Health is developing BLU-5937, a P2X3 antagonist, to help people with chronic cough and other afferent hypersensitization-related disorders. Headquarters is in Canada.
World Top 100 Healthcare Companies List by Market Cap in January 2024, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as pf Jan-05-2024.
BELLUS Health is developing BLU-5937, a P2X3 antagonist, to help people with chronic cough and other afferent hypersensitization-related disorders. Headquarters is in Canada.
Catalyst Pharmaceuticals is a Biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular and neurological diseases. The headquarters is in USA.
Catalyst Pharmaceuticals Annual Total Revenue for year ending Dec-2022 was 214 million USD and and Net Income for year ending Dec-2022 was 83 million USD.
Catalyst Pharmaceuticals Annual Total Revenue for year ending Dec-2021 was 140 million USD and and Net Income for year ending Dec-2021 was 39 million USD.
As on 2022, Catalyst Pharmaceuticals has 82 employees.
ProKidney is a late clinical-stage biotech company focused on the development of a pioneering cell therapy candidate that aims to transform the treatment landscape for Chronic Kidney Disease using a patient’s own cells.
The headquarters is in USA.